Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chediak

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|March 1, 1983
Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic plateletsM H Ginsberg, J Forsyth, A Lightsey, et al.
British Journal of Haematology|May 1, 1986
Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostateJ Chediak, P Madej-Zevin, O D Ratnoff, et al.
Blood|October 1, 1981
Characterization and properties of cultured human von Willebrand umbilical vein endothelial cellsF M Booyse, A J Quarfoot, J Chediak, et al.
American Journal of Obstetrics and Gynecology|January 1, 1991
Quantitative and qualitative platelet abnormalities during pregnancyH Y How, F Bergmann, M Koshy, et al.
International Journal of Cardiology|February 3, 2005
Cardiac troponin I release in non-ischemic reversible myocardial injury from acute diphtheric myocarditisDhanunjaya R Lakkireddy, Ashok K Kondur, Ellie J Chediak, et al.
Thrombosis and Haemostasis|August 30, 1988
Further evidence of von Willebrand factor involvement in thrombotic thrombocytopenia purpuraJ Chediak, J Eldridge, F Bergmann, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1981
Fibronectin in von Willebrand's disease and thrombasthenia: role in platelet aggregationI Cohen, E V Potter, T Glaser, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1987
Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand diseaseR B Levene, F M Booyse, J Chediak, et al.
American Journal of Hematology|February 19, 2000
Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIIIH A Liebman, J Chediak, K I Fink, et al.
Blood|June 1, 1986
Carrier detection in hemophilia A: a cooperative international study. II. The efficacy of a universal discriminantP P Green, P M Mannucci, E Briët, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|March 1, 1983
Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic plateletsM H Ginsberg, J Forsyth, A Lightsey, et al.
British Journal of Haematology|May 1, 1986
Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostateJ Chediak, P Madej-Zevin, O D Ratnoff, et al.
Blood|October 1, 1981
Characterization and properties of cultured human von Willebrand umbilical vein endothelial cellsF M Booyse, A J Quarfoot, J Chediak, et al.
American Journal of Obstetrics and Gynecology|January 1, 1991
Quantitative and qualitative platelet abnormalities during pregnancyH Y How, F Bergmann, M Koshy, et al.
International Journal of Cardiology|February 3, 2005
Cardiac troponin I release in non-ischemic reversible myocardial injury from acute diphtheric myocarditisDhanunjaya R Lakkireddy, Ashok K Kondur, Ellie J Chediak, et al.
Thrombosis and Haemostasis|August 30, 1988
Further evidence of von Willebrand factor involvement in thrombotic thrombocytopenia purpuraJ Chediak, J Eldridge, F Bergmann, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1981
Fibronectin in von Willebrand's disease and thrombasthenia: role in platelet aggregationI Cohen, E V Potter, T Glaser, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1987
Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand diseaseR B Levene, F M Booyse, J Chediak, et al.
American Journal of Hematology|February 19, 2000
Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIIIH A Liebman, J Chediak, K I Fink, et al.
Blood|June 1, 1986
Carrier detection in hemophilia A: a cooperative international study. II. The efficacy of a universal discriminantP P Green, P M Mannucci, E Briët, et al.
Pageof 4